SEVERE WX : Frost Advisory View Alerts
STREAMING NOW: Watch Now

FDA approves new option for cancer patients

Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.

Posted: Nov 29, 2018 9:24 AM
Updated: Nov 29, 2018 9:44 AM

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.

Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."

The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.

Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.

NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.

Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.

Alongside the tablets, the agency also approved a diagnostic to detect the mutation.

"Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.

AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.

Both treatments were granted Priority Review designation.

Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review.

"A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.

Both treatments also received orphan drug designation, a status granted to drugs for rare diseases or conditions.

Minnesota Coronavirus Cases

Data is updated nightly.

Cases: 589527

Reported Deaths: 7333
CountyCasesDeaths
Hennepin1221311726
Ramsey51028871
Dakota45667448
Anoka41421437
Washington26724281
Stearns22139221
St. Louis17682302
Scott17201124
Wright15943139
Olmsted1319098
Sherburne1160286
Carver1044945
Clay812792
Rice8014106
Blue Earth746141
Crow Wing660988
Kandiyohi652083
Chisago592551
Otter Tail572978
Benton565997
Goodhue475772
Douglas464674
Mower464032
Winona452950
Itasca432254
McLeod421658
Isanti417364
Morrison417360
Nobles407248
Beltrami392458
Steele384915
Polk382468
Becker378850
Lyon359850
Carlton344153
Freeborn341129
Pine326722
Nicollet323843
Brown304640
Mille Lacs302452
Le Sueur289222
Todd280632
Cass269628
Meeker254340
Waseca236522
Martin229831
Roseau207919
Wabasha20483
Hubbard187141
Dodge18373
Renville178943
Redwood172936
Houston171515
Cottonwood164321
Fillmore155510
Wadena155122
Pennington153619
Chippewa151838
Faribault151319
Kanabec143424
Sibley142510
Aitkin134236
Watonwan13219
Rock128019
Jackson121711
Pipestone115126
Yellow Medicine113820
Pope10956
Murray10609
Swift104918
Stevens90211
Marshall88017
Clearwater86416
Koochiching81715
Lake80819
Wilkin80712
Lac qui Parle75022
Big Stone5984
Lincoln5773
Grant5678
Mahnomen5459
Norman5399
Unassigned48793
Kittson48522
Red Lake3957
Traverse3685
Lake of the Woods3223
Cook1610

Iowa Coronavirus Cases

Data is updated nightly.

Cases: 366197

Reported Deaths: 5929
CountyCasesDeaths
Polk57488623
Linn20814334
Scott19960240
Black Hawk15785308
Woodbury15121228
Johnson1445783
Dubuque13355209
Dallas1116198
Pottawattamie11091168
Story1059248
Warren575888
Clinton554393
Cerro Gordo538089
Sioux513874
Webster512193
Marshall482175
Muscatine477499
Des Moines454366
Wapello4297122
Buena Vista424540
Jasper418672
Plymouth400680
Lee375055
Marion361775
Jones298157
Henry291137
Carroll285452
Bremer283960
Crawford265840
Boone263934
Benton256055
Washington253950
Dickinson247843
Mahaska229951
Jackson221242
Clay215325
Kossuth215264
Delaware209240
Tama209271
Winneshiek196934
Page192622
Buchanan190731
Cedar189423
Hardin184943
Fayette184841
Wright184336
Hamilton179449
Harrison179373
Clayton169256
Butler164634
Mills161722
Madison161519
Floyd160342
Cherokee158738
Lyon157741
Poweshiek154733
Allamakee151151
Iowa148324
Hancock147634
Winnebago141731
Calhoun138113
Cass137954
Grundy136233
Emmet134040
Jefferson132435
Shelby130737
Sac130119
Union128133
Appanoose128049
Louisa127849
Mitchell126042
Chickasaw123915
Guthrie121030
Franklin119321
Humboldt118826
Palo Alto112523
Howard104522
Montgomery103338
Clarke99924
Unassigned9770
Keokuk95631
Monroe95129
Ida90334
Adair86432
Pocahontas85322
Davis82824
Monona82830
Osceola78516
Greene77610
Lucas77123
Worth7438
Taylor65712
Fremont6229
Decatur6089
Van Buren55618
Ringgold55524
Wayne53723
Audubon50810
Adams3384
Rochester
Clear
40° wxIcon
Hi: 65° Lo: 33°
Feels Like: 40°
Mason City
Clear
34° wxIcon
Hi: 66° Lo: 30°
Feels Like: 34°
Albert Lea
Partly Cloudy
41° wxIcon
Hi: 66° Lo: 29°
Feels Like: 41°
Austin
Partly Cloudy
36° wxIcon
Hi: 66° Lo: 29°
Feels Like: 36°
Charles City
Clear
° wxIcon
Hi: 66° Lo: 33°
Feels Like: °
Gradual warm-up this week
KIMT Radar
KIMT Eye in the sky

Community Events